0001214659-20-010294.txt : 20201209
0001214659-20-010294.hdr.sgml : 20201209
20201209171112
ACCESSION NUMBER: 0001214659-20-010294
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201207
FILED AS OF DATE: 20201209
DATE AS OF CHANGE: 20201209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CRANDELL KEITH
CENTRAL INDEX KEY: 0001219039
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38720
FILM NUMBER: 201378537
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD
STREET 2: SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Twist Bioscience Corp
CENTRAL INDEX KEY: 0001581280
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462058888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 800-719-0671
MAIL ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
marketforms-50520.xml
PRIMARY DOCUMENT
X0306
4
2020-12-07
0001581280
Twist Bioscience Corp
TWST
0001219039
CRANDELL KEITH
8755 W. HIGGINS ROAD, SUITE 1025
CHICAGO
IL
60631
true
false
false
false
Common Stock
2020-08-18
4
J
false
685613
0
D
1721809
I
By Arch Venture Fund VII, L.P.
Common Stock
2020-08-18
4
J
false
34845
0
A
34845
I
By Keith L.Crandall Trust
Common Stock
2020-08-18
4
J
false
248083
0
D
706063
I
By ARCH Venture Fund VIII Overage, L.P.
Common Stock
2020-08-18
4
J
false
3
0
A
34848
I
By Keith L.Crandall Trust
Common Stock
2020-09-02
4
J
false
497032
0
D
1224777
I
By Arch Venture Fund VII, L.P.
Common Stock
2020-09-02
4
J
false
25261
0
A
60109
I
By Keith L.Crandall Trust
Common Stock
2020-09-02
4
J
false
220641
0
D
485422
I
By ARCH Venture Fund VIII Overage, L.P.
Common Stock
2020-09-02
4
J
false
3
0
A
60112
I
By Keith L.Crandall Trust
Common Stock
2020-09-15
4
J
false
444231
0
D
780546
I
By Arch Venture Fund VII, L.P.
Common Stock
2020-09-15
4
J
false
22578
0
A
82690
I
By Keith L.Crandall Trust
Common Stock
2020-09-15
4
J
false
176030
0
D
309392
I
By ARCH Venture Fund VIII Overage, L.P.
Common Stock
2020-09-15
4
J
false
2
0
A
82692
I
By Keith L.Crandall Trust
Common Stock
2020-12-07
4
S
false
53712
103.40
D
726834
I
By Arch Venture Fund VII, L.P.
Common Stock
2020-12-07
4
S
false
21288
103.40
D
288104
I
By ARCH Venture Fund VIII Overage, L.P.
Common Stock
1412
D
Pro-rata distribution of Common Stock held by a limited partnership to its partners for no consideration.
The shares are directly held by ARCH Venture Fund VII, L.P. ("ARCH Fund VII"). The sole general partner of ARCH Fund VII is ARCH Venture Partners VII, L.P. ("ARCH Partners VII"), which may be deemed to be the beneficial owner of the shares held by ARCH Fund VII. The sole general partner of ARCH Partners VII is ARCH Venture Partners VII, LLC ("ARCH VII LLC"), which may be deemed to be the beneficial owner of the shares held by ARCH Fund VII. ARCH Partners VII and ARCH VII LLC disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
The shares are directly held by ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"). The sole general partner of ARCH Overage is ARCH Venture Partners VIII, LLC ("AVP GPLLC"), which may be deemed to be the beneficial owner of the shares held by ARCH Overage. AVP GPLLC disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
Keith Crandell is a managing director of ARCH VII LLC and ARCH VIII LLC, and may be deemed to beneficially own the shares held by ARCH Fund VII and ARCH Overage. Mr. Crandell disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
Change in form of ownership of shares previously reported as beneficially owned by the reporting person.
/s/ Mark Daniels, as Attorney-in-Fact for Keith Crandell
2020-12-09